Urology News and Research

Latest Urology News and Research

Robotic retroperitoneal lymph node dissection (RPLND) for testicular cancer: an interview with Dr. Stephen Williams of St. Joseph Hospital in Orange

Robotic RPLND utilizes laparoscopy combined with robotic technology to perform dissection and removal of lymph node tissue in the retroperitoneum both as a staging as well as therapeutic procedure for patients with testicular cancer.

10 Jul 2013

Robotic ultrasound to identify tumors during kidney cancer surgery gains acceptance among surgeons

While the use of ultrasound to identify tumors during kidney cancer surgery is gaining acceptance, a research team at Henry Ford Hospital has successfully taken it a step further by showing an added benefit when the procedure is done robotically.

10 Jul 2013

Bioniche, Paladin close debt refinancing agreement and sign first licensing deal for Urocidin

Bioniche Life Sciences Inc. and Paladin Labs Inc. today announced the official closing of the various agreements associated with a comprehensive strategic collaboration to refinance and increase Bioniche's debt, provide new equity, and enter into the first licensing deal for Bioniche's Phase III bladder cancer product - Urocidin.

6 Jul 2013

3-gene signature test will improve care of kidney transplant patients

A breakthrough non-invasive test can detect whether transplanted kidneys are in the process of being rejected, as well as identify patients at risk for rejection weeks to months before they show symptoms, according to a study published in The New England Journal of Medicine (NEJM).

4 Jul 2013

Tel-Aviv research shows physicians delay diagnosis of cervical spondylotic myelopathy

Researchers from The Tel-Aviv Medical Center found delays in diagnosis of cervical spondylotic myelopathy (CSM) averaging 2 years in 42 patients who eventually underwent surgery. This is an important finding, because previous studies have shown that early diagnosis and treatment of CSM lead to better outcomes.

2 Jul 2013

Study: Active surveillance does not appear to be good idea for black men with prostate cancer

A Johns Hopkins study of more than 1,800 men ages 52 to 62 suggests that African-Americans diagnosed with very-low-risk prostate cancers are much more likely than white men to actually have aggressive disease that goes unrecognized with current diagnostic approaches.

26 Jun 2013

Sorrento, IGDRASOL to present updates on IG-001 and IG-004 at joint meeting of CLINAM and ETPN

Sorrento Therapeutics, Inc. and IGDRASOL announced today that the companies will present updates of their analyses of proprietary late clinical stage paclitaxel formulations, IG-001 (Cynviloq) and IG-004 (TOCOSOL paclitaxel) at the joint meeting of the European Foundation for Clinical Nanomedicine and the European Technology Platform on Nanomedicine in Basel, Switzerland on June 23 - 26.

21 Jun 2013

Exposing tissue to low levels of BPA linked to greater incidence of prostate cancer

Exposing developing tissue to low levels of the plastic bisphenol A, commonly known as BPA, is linked to a greater incidence of prostate cancer in tissue grown from human prostate stem cells, a new study finds. The results were presented Monday, June 17, at The Endocrine Society's 95th Annual Meeting in San Francisco.

19 Jun 2013

Early exposure to BPA increases risk for prostate cancer in human prostate tissue

Early exposure to BPA (bisphenol A) - an additive commonly found in plastic water bottles and soup can liners - causes an increased cancer risk in an animal model of human prostate cancer, according to University of Illinois at Chicago researcher Gail Prins.

18 Jun 2013

IPC to distribute AP's Promescent in US for treatment of premature ejaculation

The Independent Pharmacy Cooperative and Absorption Pharmaceuticals have signed a distribution agreement whereby IPC will make AP's topical treatment for premature ejaculation, Promescent, available to its 4,500+ member pharmacies throughout the United States.

14 Jun 2013

New imaging system combines PET and MR for mapping recurrent prostate cancer

When prostate cancer makes a comeback, it becomes increasingly important to have exceptional imaging available to find all possible regions where cancer has spread to other parts of the body, or metastasized, in order to plan the best possible treatment.

12 Jun 2013

UCSF Benioff Children's Hospital earns top ranking

UCSF Benioff Children's Hospital ranks among the nation's best children's hospitals in nine specialties and is one of the top-ranked centers in California, according to the 2013-14 Best Children's Hospitals survey conducted by the U.S. News Media Group.

12 Jun 2013

Home treatment improves chronic constipation in children

Home treatment with a simple, battery-operated system that applies four sticky electrode patches to the mid-section allowed a group of children with the most difficult-to-treat, possibly congenital, constipation to reduce soiling and improve elimination, according to results presented today at the 11th World Congress of the International Neuromodulation Society.

12 Jun 2013

C.S. Mott Children's Hospital ranked among nation's best children's hospitals

The University of Michigan's C.S. Mott Children's Hospital is among the best children's hospitals in the country in pediatric specialties and is the only hospital in Michigan ranked in all 10 specialties evaluated, according to the U.S. News & World Report's 2013-14 Best Children's Hospitals rankings.

12 Jun 2013

Prostate cancer and DNA: an interview with Dr. Jianfeng Xu, Wake Forest School of Medicine

Prostate cancer development is associated with both inherited and acquired genetic alterations. More than 70 inherited genetic variants have been consistently identified in human DNA that may contribute to susceptibility or risk of prostate cancer.

11 Jun 2013

Children's Hospitals and Clinics of Minnesota honored as 2013-2014 Best Children's Hospital

Children's Hospitals and Clinics of Minnesota has been honored by U.S. News & World Report as a 2013-2014 Best Children's Hospital. Children's has been ranked on the list every year since the program's inception in 2007.

11 Jun 2013

International clinical study shows that BioProtect Balloon Implant has potential to reduce rectal injury

Several years ago, Virginia Commonwealth University Massey Cancer Center became the first center in the United States to test an Israeli-invented device designed to increase the space between the prostate and the rectum in prostate cancer patients undergoing radiation therapy.

11 Jun 2013

Novel abnormalities in FGFR gene identified in a spectrum of cancers

Novel abnormalities in the FGFR gene, called FGFR fusions, were identified in a spectrum of cancers, and preliminary results with cancer cells harboring FGFR fusions suggested that some patients with these cancers may benefit from treatment with FGFR inhibitor drugs, according to data published in Cancer Discovery, a journal of the American Association for Cancer Research.

10 Jun 2013

Actavis files ANDA to market Propofol Injection

Actavis, Inc. today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Propofol Injection 10mg/mL.

7 Jun 2013

Instillation of chemotherapy can minimize recurrence and progression of bladder cancer

Researchers at UCLA's Jonsson Comprehensive Cancer Center led by Dr. Karim Chamie have found that more intense surveillance and treatment of bladder cancer in the first two years after diagnosis could reduce the number of patients whose cancer returns after treatment and lower the disease's death rate. The study was published online ahead of press today in the journal Cancer.

6 Jun 2013

Urology News and Research

Latest Urology News and Research

Robotic retroperitoneal lymph node dissection (RPLND) for testicular cancer: an interview with Dr. Stephen Williams of St. Joseph Hospital in Orange

Robotic ultrasound to identify tumors during kidney cancer surgery gains acceptance among surgeons

Bioniche, Paladin close debt refinancing agreement and sign first licensing deal for Urocidin

3-gene signature test will improve care of kidney transplant patients

Tel-Aviv research shows physicians delay diagnosis of cervical spondylotic myelopathy

Study: Active surveillance does not appear to be good idea for black men with prostate cancer

Sorrento, IGDRASOL to present updates on IG-001 and IG-004 at joint meeting of CLINAM and ETPN

Exposing tissue to low levels of BPA linked to greater incidence of prostate cancer

Early exposure to BPA increases risk for prostate cancer in human prostate tissue

IPC to distribute AP's Promescent in US for treatment of premature ejaculation

New imaging system combines PET and MR for mapping recurrent prostate cancer

UCSF Benioff Children's Hospital earns top ranking

Home treatment improves chronic constipation in children

C.S. Mott Children's Hospital ranked among nation's best children's hospitals

Prostate cancer and DNA: an interview with Dr. Jianfeng Xu, Wake Forest School of Medicine

Children's Hospitals and Clinics of Minnesota honored as 2013-2014 Best Children's Hospital

International clinical study shows that BioProtect Balloon Implant has potential to reduce rectal injury

Novel abnormalities in FGFR gene identified in a spectrum of cancers

Actavis files ANDA to market Propofol Injection

Instillation of chemotherapy can minimize recurrence and progression of bladder cancer

Industry Focus eBook - Pharmaceutical Manufacturing (1st edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Urology News and Research

Latest Urology News and Research

Industry Focus eBook - Pharmaceutical Manufacturing (1st edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in